NEW YORK (GenomeWeb News) – Ariosa Diagnostics today said it has reached a deal with Fleury Medicina e Saude (Fleury Group) to provide Ariosa's non-invasive prenatal diagnostic test in Brazil.

The Fleury Group will distribute the Harmony Prenatal Test within its network of more than 3,000 clinical laboratories and hospitals throughout the country, which Ariosa said has an annual birth rate of almost 3 million.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers hope to tease out the signature effects that different carcinogens leave on the genome to determine their contributions to disease, Mosaic reports.

The Wall Street Journal looks into the cost of new gene therapies.

An Imperial College London-led team reports that it was able to use a gene drive to control a population of lab mosquitos.

In PNAS this week: genomic effects of silver fox domestication, limited effect of mitochondrial mutations on aging in fruit flies, and more.